Form 4: Cellebrite Executive Sells Shares for Tax Obligations

Cellebrite Chief Marketing Officer David Gee sold company shares to cover tax liabilities related to vested restricted stock units, as disclosed in a Form 4 filing.

Summary

• David N. Gee, Chief Marketing Officer of Cellebrite DI Ltd. (CLBT), reported the disposition of ordinary shares.
• The transactions occurred on May 21, 2026, involving a total of 2,243 shares at a weighted average price of $13.10.
• An additional 3,430 shares were disposed of at a weighted average price of $13.1468.
• These dispositions were made to cover tax obligations arising from the vesting of restricted stock units (RSUs) granted on May 20, 2024.
• The sales were executed under a Rule 10b5-1 trading plan adopted on November 18, 2025.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as slightly negative due to the insider selling, even though it is explained by tax obligations and a pre-arranged trading plan. The market's perception can still be influenced by the act of selling.

Negatives

• Company shares were sold by a key executive, potentially signaling a lack of confidence or a need for liquidity, although the stated reason is tax settlement.
• The weighted average sale prices indicate a disposition of shares at a market rate, not necessarily at a premium or discount.

Risks

• The disposition of shares by a Chief Marketing Officer could be perceived negatively by the market, potentially impacting investor sentiment.
• While the sales are attributed to tax obligations, the timing and volume could be scrutinized by investors.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to insider stock transactions.

Management Comments

• The shares reported as disposed herein were granted on May 20, 2024, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.
• The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025.

Industry Context

StockSavvy.ai notes that insider sales, particularly those related to tax obligations or pre-arranged trading plans like Rule 10b5-1, are common. However, the market often interprets any insider selling as a potential negative signal, regardless of the underlying reason.

Stakeholder Impact

• Shareholders may view the sale of shares by a key executive with caution, potentially leading to short-term negative sentiment.
• Employees with RSUs may take note of the tax implications and the use of Rule 10b5-1 plans for managing their own holdings.

Key Dates

Recommendation

This filing primarily details routine stock dispositions by an executive for tax purposes under a pre-established plan. While insider selling can be a negative signal, the clear explanation and the use of a 10b5-1 plan mitigate significant concern for a 'hold' recommendation. Further analysis of Cellebrite's core business performance is required for a stronger recommendation.

Keywords

Cellebrite, CLBT, Form 4, Insider Trading, Stock Sale, RSU Vesting, Tax Obligations, Rule 10b5-1, David Gee, Chief Marketing Officer